Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

The new particle system could be a promising treatment for diseases related to the 5-α reductase enzyme.

5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

PNU157706 reduced rat sperm movement and fertility without affecting offspring health.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Special nanoparticles increased skin absorption of hair loss treatments with fewer side effects.

Gene variant linked to prostate cancer, hormone levels, and hair loss.

Dutasteride more effective for hair growth, but has more side effects than finasteride.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Finasteride and dutasteride effectively treat hair loss, but may cause side effects like sexual dysfunction and depression.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Ketoconazole increases finasteride's effectiveness and lifespan in the body.

Finasteride raises suicide-linked aggression and stops clozapine's positive effects in schizophrenia animals.

Dutasteride reduces DHT more effectively than finasteride.

The research shows that hydrogen bonds greatly affect the crystal structure of a Finasteride derivative.

Dihydrotestosterone treatment can help penis growth in boys with 5α-reductase deficiency but doesn't fully normalize size after puberty.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Two types of 5α-reductase are in dog skin, which might make dutasteride better than finasteride for treating dog hair loss.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Finasteride affects urinary steroid profiles and can potentially hide steroid abuse in sports drug testing.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Dutasteride may help shrink prostate cancer tumors.